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ABSTRACT:  
 
BACKGROUND: Multiple Sclerosis (MS) is a disease with a wide-ranging impact on 
functional status. MS patient function has been assessed using Multiple Sclerosis Functional 
Composite Score (MSFCS). The MSFCS includes the standardized scores (Z-score) of three 
functional tests: the Paced Auditory Serial Addition Test (PASAT-3”) for cognitive function, 9-
Hole Peg Test (9-HPT) for upper extremity function, and timed 25-foot walk (25-TW) for lower 
extremity function. One of the most common symptoms experienced by MS patients is severe 
fatigue, often brought on suddenly by aerobic exercise.  Non-aerobic maximal effort exercise 
(MEE) is thought to increase strength without increasing fatigue. The IsoPUMP® 
(Neuromuscular Engineering; Nashville, TN) is a stationary exercise device designed for patient 
use to safely perform MEE leg presses and whole body lunges using isometric and eccentric 
exercises. The progressive functional changes of the MS patients were tracked using the MSFCs 
at specific intervals during the study. 
HYPOTHESIS: An observed functional improvement in patients will be reflected in their 
MSFCS as well as the individual PASAT-3”, 9-HPT, and 25-TW tests. 
MATERIALS & METHODS:  A total of 78 subjects, diagnosed with MS for at least 2 years, 
participated in this multi-centered study.  During the baseline period, subjects completed 
questionnaires and performed the 25-TW, 9-HPT, and PASAT-3” test.  A four-phase exercise 
protocol was implemented using leg press and whole body lunge exercises performed on the 
IsoPUMP® bi-weekly for 10 weeks and once during weeks 16 and 22. Subjects were instructed 
to perform a valsalva while exerting their maximal effort against the IsoPUMP® resistance for 4 
seconds per repetition.  This was repeated several times with minimal rest (60-180 seconds) 
between progressively more repetitions (3 at onset; 5 after week 7.) Effect size, calculated by 
comparing baseline (Week 0) mean MSFC Z-score values to values obtained from subsequent 
weeks, was employed to determine the statistical significance of the improved function and 
strength.  
RESULTS: Significant improvements in the cognitive function (Effect Size =0.64, p-value< 
0.001), lower extremity function (Effect Size=0.39, p-value=0.001) and overall MSFC (Effect 
Size = 0.32, p-value< 0.001) were noted twelve weeks post-MEE treatment.  However, the 
changes in the upper extremity function were not statistically significant. 
CONCLUSION:  When comparing MS subject’s  functional status to baseline, it was noted that 
the subjects showed significant improvement in cognition (moderate) and lower extremity 
function (mild), with prolonged effects lasting twelve weeks post MEE treatment.  Although 
changes in upper extremity function were not statistically significant, an improvement in overall 
function, quantified as an enhanced MSFC score, was noted over the 6-month total observation 
time. While an effect-size of 0.32 for overall MSFC indicates a mild statistical improvement, it is 
considerably significant in this patient population, where the underlying disease process 
predisposes them to deterioration in function over time.  
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